Imeik Technology Development Co Ltd Class A

300896: XSHE (CHN)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
NWDLOCK|!nb%VLOCK|xrvNnTV

Imeik's Market Positioning Remains Resilient Despite Higher Structural Costs

Business Strategy and Outlook

Imeik produces medical aesthetic fillers with two main segments, gel and solution, primarily in China. Historically dominated by foreign brands, domestic brands like Imeik have increased market share as they gain consumer acceptance. Given Imeik’s established brand and distribution network, we expect it to benefit greatly from the growing medical aesthetic penetration in China.

Sponsor Center